Export translations
Jump to navigation
Jump to search
Settings
Group
Coil
ENDS Cardiovascular System
ENDS EVALI VALI THCVALI
ENDS Flavors
ENDS Positive study collection
ENDS Respiratory System
ENDS Taxes
ENDS The Fight to Abolish an Industry
ENDS Toxicity / Carcinogenic
ENDS Youth & Young Adults
Main Page
Mythbusters
Nicotine / THR - Change the Conversation
Nicotine / THR - Guides for Policymakers & Advocates
Nicotine / THR - Statements from Organizations
Nicotine Replacement Therapy
Nicotine Studies
Nicotine therapeutic benefits
Ohms law
Safer Nicotine Wiki:About
Safer Nicotine Wiki:Copyrights
Safer Nicotine Wiki:General disclaimer
Tobacco Harm Reduction News
Language
aa - Afar
aae - Arbëresh
ab - Abkhazian
abs - Ambonese Malay
ace - Achinese
acm - Iraqi Arabic
ady - Adyghe
ady-cyrl - Adyghe (Cyrillic script)
aeb - Tunisian Arabic
aeb-arab - Tunisian Arabic (Arabic script)
aeb-latn - Tunisian Arabic (Latin script)
af - Afrikaans
aln - Gheg Albanian
alt - Southern Altai
am - Amharic
ami - Amis
an - Aragonese
ang - Old English
ann - Obolo
anp - Angika
ar - Arabic
arc - Aramaic
arn - Mapuche
arq - Algerian Arabic
ary - Moroccan Arabic
arz - Egyptian Arabic
as - Assamese
ase - American Sign Language
ast - Asturian
atj - Atikamekw
av - Avaric
avk - Kotava
awa - Awadhi
ay - Aymara
az - Azerbaijani
azb - South Azerbaijani
ba - Bashkir
ban - Balinese
ban-bali - Balinese (Balinese script)
bar - Bavarian
bbc - Batak Toba
bbc-latn - Batak Toba (Latin script)
bcc - Southern Balochi
bci - Baoulé
bcl - Central Bikol
bdr - West Coast Bajau
be - Belarusian
be-tarask - Belarusian (Taraškievica orthography)
bew - Betawi
bg - Bulgarian
bgn - Western Balochi
bh - Bhojpuri
bho - Bhojpuri
bi - Bislama
bjn - Banjar
blk - Pa'O
bm - Bambara
bn - Bangla
bo - Tibetan
bpy - Bishnupriya
bqi - Bakhtiari
br - Breton
brh - Brahui
bs - Bosnian
btm - Batak Mandailing
bto - Iriga Bicolano
bug - Buginese
bxr - Russia Buriat
ca - Catalan
cbk-zam - Chavacano
cdo - Mindong
ce - Chechen
ceb - Cebuano
ch - Chamorro
chn - Chinook Jargon
cho - Choctaw
chr - Cherokee
chy - Cheyenne
ckb - Central Kurdish
co - Corsican
cps - Capiznon
cpx - Pu–Xian Min
cpx-hans - Pu–Xian Min (Simplified Han script)
cpx-hant - Pu–Xian Min (Traditional Han script)
cpx-latn - Pu–Xian Min (Latin script)
cr - Cree
crh - Crimean Tatar
crh-cyrl - Crimean Tatar (Cyrillic script)
crh-latn - Crimean Tatar (Latin script)
crh-ro - Dobrujan Tatar
cs - Czech
csb - Kashubian
cu - Church Slavic
cv - Chuvash
cy - Welsh
da - Danish
dag - Dagbani
de - German
de-at - Austrian German
de-ch - Swiss High German
de-formal - German (formal address)
dga - Dagaare
din - Dinka
diq - Zazaki
dsb - Lower Sorbian
dtp - Central Dusun
dty - Doteli
dv - Divehi
dz - Dzongkha
ee - Ewe
efi - Efik
egl - Emilian
el - Greek
eml - Emiliano-Romagnolo
en - English
en-ca - Canadian English
en-gb - British English
eo - Esperanto
es - Spanish
es-419 - Latin American Spanish
es-formal - Spanish (formal address)
et - Estonian
eu - Basque
ext - Extremaduran
fa - Persian
fat - Fanti
ff - Fula
fi - Finnish
fit - Tornedalen Finnish
fj - Fijian
fo - Faroese
fon - Fon
fr - French
frc - Cajun French
frp - Arpitan
frr - Northern Frisian
fur - Friulian
fy - Western Frisian
ga - Irish
gaa - Ga
gag - Gagauz
gan - Gan
gan-hans - Gan (Simplified Han script)
gan-hant - Gan (Traditional Han script)
gcf - Guadeloupean Creole
gcr - Guianan Creole
gd - Scottish Gaelic
gl - Galician
gld - Nanai
glk - Gilaki
gn - Guarani
gom - Goan Konkani
gom-deva - Goan Konkani (Devanagari script)
gom-latn - Goan Konkani (Latin script)
gor - Gorontalo
got - Gothic
gpe - Ghanaian Pidgin
grc - Ancient Greek
gsw - Alemannic
gu - Gujarati
guc - Wayuu
gur - Frafra
guw - Gun
gv - Manx
ha - Hausa
hak - Hakka Chinese
haw - Hawaiian
he - Hebrew
hi - Hindi
hif - Fiji Hindi
hif-latn - Fiji Hindi (Latin script)
hil - Hiligaynon
hno - Northern Hindko
ho - Hiri Motu
hr - Croatian
hrx - Hunsrik
hsb - Upper Sorbian
hsn - Xiang
ht - Haitian Creole
hu - Hungarian
hu-formal - Hungarian (formal address)
hy - Armenian
hyw - Western Armenian
hz - Herero
ia - Interlingua
ibb - Ibibio
id - Indonesian
ie - Interlingue
ig - Igbo
igl - Igala
ii - Sichuan Yi
ik - Inupiaq
ike-cans - Eastern Canadian (Aboriginal syllabics)
ike-latn - Eastern Canadian (Latin script)
ilo - Iloko
inh - Ingush
io - Ido
is - Icelandic
it - Italian
iu - Inuktitut
ja - Japanese
jam - Jamaican Creole English
jbo - Lojban
jut - Jutish
jv - Javanese
ka - Georgian
kaa - Kara-Kalpak
kab - Kabyle
kai - Karekare
kbd - Kabardian
kbd-cyrl - Kabardian (Cyrillic script)
kbp - Kabiye
kcg - Tyap
kea - Kabuverdianu
kg - Kongo
kge - Komering
khw - Khowar
ki - Kikuyu
kiu - Kirmanjki
kj - Kuanyama
kjh - Khakas
kjp - Eastern Pwo
kk - Kazakh
kk-arab - Kazakh (Arabic script)
kk-cn - Kazakh (China)
kk-cyrl - Kazakh (Cyrillic script)
kk-kz - Kazakh (Kazakhstan)
kk-latn - Kazakh (Latin script)
kk-tr - Kazakh (Turkey)
kl - Kalaallisut
km - Khmer
kn - Kannada
ko - Korean
ko-kp - Korean (North Korea)
koi - Komi-Permyak
kr - Kanuri
krc - Karachay-Balkar
kri - Krio
krj - Kinaray-a
krl - Karelian
ks - Kashmiri
ks-arab - Kashmiri (Arabic script)
ks-deva - Kashmiri (Devanagari script)
ksh - Colognian
ksw - S'gaw Karen
ku - Kurdish
ku-arab - Kurdish (Arabic script)
ku-latn - Kurdish (Latin script)
kum - Kumyk
kus - Kʋsaal
kv - Komi
kw - Cornish
ky - Kyrgyz
la - Latin
lad - Ladino
lb - Luxembourgish
lbe - Lak
lez - Lezghian
lfn - Lingua Franca Nova
lg - Ganda
li - Limburgish
lij - Ligurian
liv - Livonian
lki - Laki
lld - Ladin
lmo - Lombard
ln - Lingala
lo - Lao
loz - Lozi
lrc - Northern Luri
lt - Lithuanian
ltg - Latgalian
lus - Mizo
luz - Southern Luri
lv - Latvian
lzh - Literary Chinese
lzz - Laz
mad - Madurese
mag - Magahi
mai - Maithili
map-bms - Basa Banyumasan
mdf - Moksha
mg - Malagasy
mh - Marshallese
mhr - Eastern Mari
mi - Māori
min - Minangkabau
mk - Macedonian
ml - Malayalam
mn - Mongolian
mnc - Manchu
mnc-latn - Manchu (Latin script)
mnc-mong - Manchu (Mongolian script)
mni - Manipuri
mnw - Mon
mo - Moldovan
mos - Mossi
mr - Marathi
mrh - Mara
mrj - Western Mari
ms - Malay
ms-arab - Malay (Jawi script)
mt - Maltese
mus - Muscogee
mwl - Mirandese
my - Burmese
myv - Erzya
mzn - Mazanderani
na - Nauru
nah - Nāhuatl
nan - Minnan
nap - Neapolitan
nb - Norwegian Bokmål
nds - Low German
nds-nl - Low Saxon
ne - Nepali
new - Newari
ng - Ndonga
nia - Nias
nit - కొలామి
niu - Niuean
nl - Dutch
nl-informal - Dutch (informal address)
nmz - Nawdm
nn - Norwegian Nynorsk
no - Norwegian
nod - Northern Thai
nog - Nogai
nov - Novial
nqo - N’Ko
nrm - Norman
nso - Northern Sotho
nv - Navajo
ny - Nyanja
nyn - Nyankole
nyo - Nyoro
nys - Nyungar
oc - Occitan
ojb - Northwestern Ojibwa
olo - Livvi-Karelian
om - Oromo
or - Odia
os - Ossetic
pa - Punjabi
pag - Pangasinan
pam - Pampanga
pap - Papiamento
pcd - Picard
pcm - Nigerian Pidgin
pdc - Pennsylvania German
pdt - Plautdietsch
pfl - Palatine German
pi - Pali
pih - Norfuk / Pitkern
pl - Polish
pms - Piedmontese
pnb - Western Punjabi
pnt - Pontic
prg - Prussian
ps - Pashto
pt - Portuguese
pt-br - Brazilian Portuguese
pwn - Paiwan
qqq - Message documentation
qu - Quechua
qug - Chimborazo Highland Quichua
rgn - Romagnol
rif - Riffian
rki - Arakanese
rm - Romansh
rmc - Carpathian Romani
rmy - Vlax Romani
rn - Rundi
ro - Romanian
roa-tara - Tarantino
rsk - Pannonian Rusyn
ru - Russian
rue - Rusyn
rup - Aromanian
ruq - Megleno-Romanian
ruq-cyrl - Megleno-Romanian (Cyrillic script)
ruq-latn - Megleno-Romanian (Latin script)
rut - Rutul
rw - Kinyarwanda
ryu - Okinawan
sa - Sanskrit
sah - Yakut
sat - Santali
sc - Sardinian
scn - Sicilian
sco - Scots
sd - Sindhi
sdc - Sassarese Sardinian
sdh - Southern Kurdish
se - Northern Sami
se-fi - Northern Sami (Finland)
se-no - Northern Sami (Norway)
se-se - Northern Sami (Sweden)
sei - Seri
ses - Koyraboro Senni
sg - Sango
sgs - Samogitian
sh - Serbo-Croatian
sh-cyrl - Serbo-Croatian (Cyrillic script)
sh-latn - Serbo-Croatian (Latin script)
shi - Tachelhit
shi-latn - Tachelhit (Latin script)
shi-tfng - Tachelhit (Tifinagh script)
shn - Shan
shy - Shawiya
shy-latn - Shawiya (Latin script)
si - Sinhala
simple - Simple English
sjd - Kildin Sami
sje - Pite Sami
sk - Slovak
skr - Saraiki
skr-arab - Saraiki (Arabic script)
sl - Slovenian
sli - Lower Silesian
sm - Samoan
sma - Southern Sami
smn - Inari Sami
sms - Skolt Sami
sn - Shona
so - Somali
sq - Albanian
sr - Serbian
sr-ec - Serbian (Cyrillic script)
sr-el - Serbian (Latin script)
srn - Sranan Tongo
sro - Campidanese Sardinian
ss - Swati
st - Southern Sotho
stq - Saterland Frisian
sty - Siberian Tatar
su - Sundanese
sv - Swedish
sw - Swahili
syl - Sylheti
szl - Silesian
szy - Sakizaya
ta - Tamil
tay - Tayal
tcy - Tulu
tdd - Tai Nuea
te - Telugu
tet - Tetum
tg - Tajik
tg-cyrl - Tajik (Cyrillic script)
tg-latn - Tajik (Latin script)
th - Thai
ti - Tigrinya
tk - Turkmen
tl - Tagalog
tly - Talysh
tly-cyrl - Talysh (Cyrillic script)
tn - Tswana
to - Tongan
tok - Toki Pona
tpi - Tok Pisin
tr - Turkish
tru - Turoyo
trv - Taroko
ts - Tsonga
tt - Tatar
tt-cyrl - Tatar (Cyrillic script)
tt-latn - Tatar (Latin script)
ttj - Tooro
tum - Tumbuka
tw - Twi
ty - Tahitian
tyv - Tuvinian
tzm - Central Atlas Tamazight
udm - Udmurt
ug - Uyghur
ug-arab - Uyghur (Arabic script)
ug-latn - Uyghur (Latin script)
uk - Ukrainian
ur - Urdu
uz - Uzbek
uz-cyrl - Uzbek (Cyrillic script)
uz-latn - Uzbek (Latin script)
ve - Venda
vec - Venetian
vep - Veps
vi - Vietnamese
vls - West Flemish
vmf - Main-Franconian
vmw - Makhuwa
vo - Volapük
vot - Votic
vro - Võro
wa - Walloon
wal - Wolaytta
war - Waray
wls - Wallisian
wo - Wolof
wuu - Wu
wuu-hans - Wu (Simplified Han script)
wuu-hant - Wu (Traditional Han script)
xal - Kalmyk
xh - Xhosa
xmf - Mingrelian
xsy - Saisiyat
yi - Yiddish
yo - Yoruba
yrl - Nheengatu
yue - Cantonese
yue-hans - Cantonese (Simplified Han script)
yue-hant - Cantonese (Traditional Han script)
za - Zhuang
zea - Zeelandic
zgh - Standard Moroccan Tamazight
zh - Chinese
zh-cn - Chinese (China)
zh-hans - Simplified Chinese
zh-hant - Traditional Chinese
zh-hk - Chinese (Hong Kong)
zh-mo - Chinese (Macau)
zh-my - Chinese (Malaysia)
zh-sg - Chinese (Singapore)
zh-tw - Chinese (Taiwan)
zu - Zulu
Format
Export for off-line translation
Export in native format
Export in CSV format
Fetch
<languages/> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> [[File:WinningLosing.jpeg|There's only 1 "winner"]] </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> '''The war to end smoking has turned into the war on nicotine.''' </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> The focus has been lost, and who the "winners" and "losers" will be has changed. It is now Tobacco Control (TC) and Public Health (PH) vs. Tobacco Harm Reduction (THR). Caught in the middle are consumers who smoke, consumers who used to smoke, and industry stakeholders. AS TC/PH fights THR with both sides trying to "win" against the other, the world has forgotten the real "winners" and "losers". '''People who succeed at quitting smoking are the only real winners in this battle. People who die from smoking are the only losers in this fight. This is what we should be concerned about - people who smoke.''' It is time to #ChangeTheConversation. For TC/PH and THR to sit down and talk real solutions. Work on ways to limit initiation of smoking (and all age restricted products) while keeping Safer Nicotine (THR) products on the market for adults who smoke. </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> We need to listen to the people and orgs below, who have put out the call to '''Change The Conversation'''. </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ='''Educators'''= </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2021, Apr 30 - [https://www.frankfurt-university.de/fileadmin/standard/2021-30-04_Prof._Dr._Sto__ver_Stellungnahme_SC_HEER_Report.pdf Statement addressing the Scheer Report by Professor Heino Stöver]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *Via Google Translate: "We can only achieve our ideal of a smoke-free continent if we finally include the harm reduction approach on an equal footing in anti-smoking policy. An open-ended debate would be a first step in the right direction on the EU side and could enable many smokers to switch to less harmful products." </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2020, Aug 10 - [https://academic.oup.com/ntr/article/23/1/36/5890529 Polarization Within the Field of Tobacco and Nicotine Science and its Potential Impact on Trainees]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *Divisive, dominant perspectives on e-cigarettes move the field of nicotine and tobacco science away from scientifically rigorous discourse on this important public health topic, which involves millions of lives at stake. If norms do not change, the polarized climate may pressure trainees to choose or inherit an allegiance towards an uncompromising, one-sided stance. That allegiance can then restrict career development, undermine the credibility of research, and hinder public health progress. There is an urgent need to act to avoid negatively affecting the next generation of nicotine and tobacco research scientists. Though we have suggested some solution-oriented ideas, we are calling for reflection among everyone in the field and particularly among those with influence and power. *There are important questions that must be addressed, including: (1) as the field continues to conquer a range of research questions on e-cigarettes across a range of disciplines and career levels, how can we work better together toward the shared end goal of eliminating tobacco-related disease and death?; (2) how can scientists who perpetuate polarized viewpoints be incentivized and supported to improve?; (3) to whom can junior scientists turn for help with navigating the polarization in the field?; and (4) how can the academic community avoid contributing to the polarization that seems to pervade the field? </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2020, Apr 23 - [https://pubmed.ncbi.nlm.nih.gov/32335031/ Tobacco harm reduction: Past history, current controversies and a proposed approach for the future]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *To date, more attention has been paid on the virtues or vices of potential harm reduction products such as e-cigarettes with less focus on cigarettes, which prematurely kills half of its long-term consumers. Most in the tobacco control community would agree that an immediate main goal is to rapidly eliminate tobacco-related death and disease. To effectively achieve this goal, a more cohesive and unified approach is urgently needed before million more lives are lost to tobacco use. *Perhaps this approach could be achieved by convening yet another strategic dialogue on harm reduction that is led by one of the governmental agencies, a scientific organization and/or by respected scientists who are not strongly associated with one particular ideology. At this meeting, the current and evolving science, modeling that projects population health effects under different scenarios, identification of research gaps and consensus on a potential path towards a sensible and agreeable harm minimization approach can be developed. Keeping focus on how best to regulate combusted tobacco products and ANDS and allowing tobacco harm reduction as a component of a comprehensive tobacco control program would be one such approach. </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2018 [https://sci-hub.st/10.1080/09581596.2018.1550252 Caught in the middle: early career researchers, public health and the emotional production of research]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *In this short report, I discuss how public health research, its assessment, and its dissemination outside the academy are produced, in part, through emotional circumstances. Using current debates on e-cigarettes as an example, I show that researchers find themselves uncomfortably positioned in complicated moral and affective landscapes, often making it difficult to represent the nuance of their research. *Mair and Kierans (2007, p. 109) warned us some time ago that: ‘adopting any normative stance towards tobacco, whether pro- or anti-, would actually interfere with our capacity to document and interpret the significance of tobacco in the lives of those we study’. This statement transfers to the contemporary e-cigarette situation. </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ='''Lawmakers / Public Officials'''= </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2021 Mar 23 - [https://manilastandard.net/business/economy-trade/350219/lawmakers-ask-gov-t-to-repeal-unlawful-csc-circular-against-tobacco-companies.html Lawmakers ask gov’t to repeal ‘unlawful’ CSC circular against tobacco companies]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *(Referring to influence from out of country NGO's) "We should not be misdirected by these interest-groups that instead of helping our country in our time of need, work to set us against each other." </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ='''Tobacco Control / Public Health'''= </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2021, Mar 29 [https://www.philanthropy.com/article/vaping-and-philanthropy-debating-strategies-that-work Letters to the Editor (see letter #2): Vaping and Philanthropy: Debating Strategies That Work]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *Written By: Eric N. Lindblom, Senior Scholar, O’Neill Institute for National & Global Health Law, Georgetown University Law Center *Lindblom was director of the Office of Policy at FDA’s Center for Tobacco Products from 2011 to 2014. *Mark Gunther’s article on Bloomberg’s funding of efforts to prevent youth e-cigarette use did a good job presenting the current conflicts in the public-health community about e-cigarettes and how best to regulate them. But it did not suggest any ways those conflicts might be resolved or, perhaps, made less important. *Given the common, overriding goal of reducing tobacco-nicotine deaths and harms as quickly as possible, there are many new tobacco-control policies that all sides of the e-cigarette conflict should be able to agree on and actively support. *Even those arguing for stronger restrictions on e-cigarettes could at a minimum agree that government tax and price measures should not make e-cigarettes more expensive than smoked tobacco products. *Another possible consensus antismoking strategy might not raise any significant conflicts, even if it were extended to e-cigarettes (or to all tobacco products). That is requiring that all tobacco products be sold only in adult-only sales outlets. *To promote switching from smoking to vaping (without any downside risks), even those opposing an e-cigarette harm-reduction approach should also be able to agree that all sales outlets that sell smoked tobacco products should be required to offer e-cigarettes, as well (but not vice versa). </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2021, Mar 4 - [https://safernicotine.wiki/mediawiki/index.php/Cliff_Douglas Cliff Douglas] Manifesto: [https://drive.google.com/file/d/1C1nk1XEZ8WhnOXtCGTqHdeqomc9HOuko/view It is Time to Act with Integrity and End the Internecine Warfare Over E-Cigarettes]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *"I urge all of us in the tobacco control community to climb out of the bunker, come to the table, and try to genuinely work together. Stop skirting the truth when it feels inconvenient and open your minds and ears to all of the science that is before us. But the same goes for my other community, with whom I agree regarding the evidence-based promise of THR, but which also bears some responsibility for the adversarial nature of the relationship and for not consistently acknowledging areas of ambiguity or concern, including significant rates of experimentation with vaping by youth and youth-oriented marketing by some segments of the vaping industry. We won’t come together if we don’t come together." </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2020 - [https://drive.google.com/file/d/1CBmxmTeclgKWjA-_7P3GQrddeOkEISIt/view E-Cigarettes, Harm Reduction, and Tobacco Control: A Path Forward?]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *"Consider that in the few minutes it took to review the points in this Commentary, approximately 25 Americans and 300 people worldwide died of complications arising from their use of combusted tobacco. This is a toll that should be unacceptable to all of us, no matter where one stands on the issues presented here. We should not and can not continue to engage in the divisive and shameful conflict that the e-cigarette era has visited upon the tobacco-control community; the lives of too many people are at stake. We can and must do better and move on to the combusted tobacco endgame." </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2018 - [https://academic.oup.com/ntr/article/21/10/1299/4990310 How to Think—Not Feel—about Tobacco Harm Reduction]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *Taken literally, tobacco harm reduction—reducing the harms created by tobacco—is what everyone in tobacco control wants to accomplish. But, the term “tobacco harm reduction” (THR) has become the source of one of the most divisive, often acrimonious debates in tobacco control history. Intense emotions, on both sides, have obstructed objective consideration of complicated THR issues. *Participants on both sides of the divisive THR debate need to examine the complicated issues and evidence more objectively. This entails considering both the potential benefits and costs associated with reduced-risk products like e-cigarettes. *THR can be a complement to, not a substitute for, evidenced-based tobacco control interventions. Tobacco control professionals need to focus on objective assessment of and discussion about the potential costs and benefits of THR. *Importantly, we need to assess that evidence in a fair and objective manner, and to move forward together toward the elimination of tobacco’s harms. That, after all, is the THR goal shared by every single tobacco control professional. </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2016 - [https://www.cspdailynews.com/tobacco/4-takeaways-zellers-nato-show-session Mitch Zeller (FDA/CTP) - The E-Cig Debate Has Been Detrimental to Harm Reduction]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *Zeller went on to discuss the all-too-familiar argument about the potential pros and cons of e-cigs and vaping, wondering if tobacco-control groups and vaping advocates were “having the wrong debate.” *“The e-cig debate has been emotional, divisive and is not advancing common ground on harm reduction,” he said. “Where and how can we apply the principle of harm reduction to this debate and find common ground? It’s been horribly ineffective to date. *“Part of the challenge with tobacco-control groups and public-health advocates is a historic distrust of the tobacco industry,” he continued. “Every sector has a role to play (in finding common ground).” </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2016 - [https://csnews.com/fdas-zeller-lets-reframe-debate-focus-nicotine FDA's Zeller: Let's Reframe Debate to Focus on Nicotine]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *Explaining this in more depth, the CTP director said "looking at nicotine differently" starts with addressing a few key points: **Recognize there is a continuum of nicotine-containing products; **Understand people smoke for the nicotine but die from the tar; and **Acknowledge the public health opportunity to move tobacco users down the risk spectrum. *"Are we having the wrong debate? For me, yes. The debate has been about e-cigarettes. It should be about nicotine," he said, adding that "someone needs to step up to the plate" and reframe the debate. Once that is successfully done, the nicotine debate needs to center on some critical questions, according to Zeller. These include: What is the longer-term use for those who need it? Is there a potential need for a period of dual use and, if so, for how long? What are the unintended consequences? Where does the principle of harm reduction come in? <br> <br> </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2015 - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959509/pdf/ntv241.pdf A Proposed Collaboration Against Big Tobacco: Common Ground Between the Vaping and Public Health Community in the United States]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *An unfortunate conflict is underway between the public health community and the vaping community over e-cigarettes' harmfulness or lack thereof. This conflict is made worse by an information vacuum that is being filled by vocal members on both sides of the debate. This conflict is avoidable; common ground exists. If both groups rally around what is in their own and the public's best interest-the end of combustible tobacco--all will benefit significantly. If not, the result may be missed opportunities, misguided alliances, and--ultimately-poorer public health. </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ='''Tobacco Harm Reduction / Other Harm Reduction Backgrounds'''= </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2021 Apr 2: Comment by Alex Wodak to blog by Clive Bates: [https://www.clivebates.com/holding-the-bloomberg-anti-vaping-propaganda-complex-to-account/ Holding the Bloomberg anti-vaping propaganda complex to account]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *"If US Government and Taliban can sit down and try to negotiate an end to military activities in Afghanistan then supporters and opponents of tobacco harm reduction should be capable of a polite and respectful discussion to identify and expand common ground. After all, both want to see a worldwide substantial and rapid reduction in smoking related deaths. Need to be carefully planned and have excellent Chair. How about it?" *[https://www.harmreductionaustralia.org.au/alex-wodak/ Alex Wodak Bio:] "Dr Alex Wodak is a physician who was Director of the Alcohol and Drug Service, St. Vincent’s Hospital, Sydney (1982-2012) but has now retired. Major interests include prevention of HIV among people who inject drugs, prevention of alcohol problems and drug policy reform. Dr. Wodak is President of the Australian Drug Law Reform Foundation and was President of the International Harm Reduction Association (1996-2004). He helped establish the first needle syringe programme and the first supervised injecting centre in Australia when both were pre-legal and often works in developing countries on HIV control among among people who inject drugs. Dr Wodak helped establish the National Drug and Alcohol Research Centre, the Australian Society of HIV Medicine and the NSW Users AIDS Association." </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2020: [https://www.thecommunityagenda.com/index.php?option=com_k2&view=item&id=230:activists-health-workers-call-for-tobacco-harm-reduction&Itemid=174 ACTIVISTS, HEALTH WORKERS CALL FOR TOBACCO HARM REDUCTION]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *"Human rights activists and health workers in Uganda have embarked on a Tobacco Harm Reduction (THR) campaign aimed at reducing or minimizing harm or risks suffered by people and communities as a result of using tobacco products." *"He stressed that the THR advocacy is not going to fight or conflict with the on going government programs, but to raise an intellectual conversation seeking a deeper understanding of THR and nicotine." </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2018: Joe Gitchell [https://www.youtube.com/watch?v=n1chwTliAyE How to feel AND think about nicotine and those who use it]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> <br> </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ='''Tobacco Industry'''= </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2021: [https://www.qeios.com/read/I3JHRX Finding ‘common ground’ on shifting sands: observations on the conflicts over product regulation]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *Commentary by: Dr. Moira Gilchrist, Vice President Strategic and Scientific Communications and Mr. Antonio Ramazzotti, Vice President Consumer Insights *We do not speak for the entire tobacco industry, but we do speak for Philip Morris International. *Businesses—and what they make—change over time because of scientific and technological advancements. In any other sector, it is unthinkable that companies with valuable expertise would be excluded from discussions on the development, commercialization and regulation of innovative technologies that fulfil consumer demand and improve lives. * There is an alternative to the author’s suggested common ground: listening to the needs, wants and opinions of people who smoke. They are the ultimate decision-makers. They will decide what course of action they want to take, provided they are empowered to do so by science-based regulation. </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2019: [https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32126-9/fulltext Philip Morris International: time for a new conversation]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> "By demonising a company that is doing exactly as the Editors demand, we might never know exactly how much of an opportunity a tobacco harm-reduction strategy will bring to public health. The only losers if this happens will be the men and women who continue to smoke." *Written by: Marian Salzman *[https://www.thelancet.com/action/showPdf?pii=S0140-6736%2819%2932126-9 PDF Version] </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ='''The Science of Disputes and Negotiations'''= </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2019: [https://www.arch.virginia.edu/gallery/doc/IEN-Tobacco-THRD-final-digital-singlepages.pdf Civil Dialogue on Tobacco, Nicotine, and Alternative Products Harm Reduction]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> *10. Engagement and Dialogue: Encourage Civil Dialogues with Broad Stakeholder Involvement **There is a need for greater civil engagement between a growing number of stakeholders and experts that includes governmental agencies, public health organizations, tobacco, nicotine and alternative product manufacturers, researchers, consumers, health care professionals, laboratory testing facilities, retailers and wholesalers, and agricultural interests. Engagement should be encouraged in both public and private sector venues. </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===[https://read.dukeupress.edu/jhppl/article/42/6/1099/132093/Minors-Moral-Psychology-and-the-Harm-Reduction Minors, Moral Psychology, and the Harm Reduction Debate: The Case of Tobacco and Nicotine]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===[https://sci-hub.se/10.1057/jphp.2009.52 Understanding the origins of anger, contempt, and disgust in public health policy disputes: Applying moral psychology to harm reduction debates]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ='''Suggestions to add to this page'''= </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===[https://www.scientificamerican.com/article/is-nicotine-all-bad/ Is Nicotine All Bad?]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===[https://sci-hub.se/10.1126/science.aba0032 Evidence, alarm, and the debate over e-cigarettes]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===[https://sloanreview.mit.edu/article/the-problem-with-certainty/ The Problem With Certainty]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===[https://rodutobaccotruth.blogspot.com/2021/07/tobacco-harm-reduction-polar-opposition.html Tobacco Harm Reduction: Polar Opposition Must be Resolved]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===[https://www.mdpi.com/1660-4601/18/11/5560 Tobacco Harm Reduction as a Path to Restore Trust in Tobacco Control]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===[https://twitter.com/INNCOorg/status/1396333154013700097 INNCO tweet about above link]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===[https://pubmed.ncbi.nlm.nih.gov/32086156/ Framing and scientific uncertainty in nicotine vaping product regulation: An examination of competing narratives among health and medical organisations in the UK, Australia and New Zealand]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===[https://drive.google.com/file/d/1tG1X2DDwY7zu4HZYl59ot9qBlJRBfKMy/view Re-thinking nicotine and its effects]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> The challenge for policy makers and regulators is to imagine how policy levers, regulations, and other tobacco control activities can be used in tandem to optimize population health: Preventing youth initiation and escalation, while helping 40 million smokers move to less harmful products and making it easier for them to quit and stay quit. </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2014 [https://www.clivebates.com/memo-to-public-health-grandees-vaping-vapers-and-you/ Memo to public health grandees: vaping, vapers and you]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2017 [https://fivethirtyeight.com/features/the-easiest-way-to-dismiss-good-science-demand-sound-science/ There’s No Such Thing As ‘Sound Science’]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> ===2021 [https://www.nature.com/articles/d41586-021-02993-7 Scientists: don’t feed the doubt machine]=== </div> <div lang="en-GB" dir="ltr" class="mw-content-ltr"> [[Category: Associated with TC/PH and THR]] [[Category:Consumer Advocacy Organization]] [[Category:Media - Movies, Videos, Vlogs, Blogs, OpEds, News, etc.]] [[Category: People of note]] [[Category: Regulations]] [[Category: THR Advocacy Group]] [[Category: Tobacco control groups]] </div>
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
More information
OK
Navigation menu
Personal tools
British English
Create account
Log in
Namespaces
Translate
British English
Views
Language statistics
Message group statistics
Export
More
Refresh
Search
Navigation
Main page
All Pages
Recent changes
Random page
Help about MediaWiki
Main Categories
Latest News
Latest news on THR, Vaping and Safer Nicotine
Get involved
How To Edit safernicotine.wiki
Create an account
Translate pages
Translator Signup
Upload Multiple Files (Upload Wizard)
Tools
Special pages
Printable version